Wealth Enhancement Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$54K 2662
2024
Q1
$54K Sell
500
-1,500
-75% -$1.07M ﹤0.01% 2339
2023
Q4
$244K Hold
2,000
﹤0.01% 1970
2023
Q3
$190K Buy
+2,000
New +$1.03M ﹤0.01% 2016

Other funds holding LLY

Wealth Enhancement Advisory Services's LLY Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $22.8M and bringing the position to 183,702 shares worth $197M. The position accounts for 0.33% of the portfolio, ranked #45.

Wealth Enhancement Advisory Services first reported a position in LLY in Q4 2015 and has held it in 34 quarters since. The position peaked at $228M in Q4 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Enhancement Advisory Services held 183,702 shares of Eli Lilly worth $197M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 22,314 Eli Lilly shares in Q2 2026, an estimated $22.8M.
  • Eli Lilly made up 0.33% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #45 holding.
  • Wealth Enhancement Advisory Services first reported a position in Eli Lilly in Q4 2015 and has held it in 34 quarters since.
  • Wealth Enhancement Advisory Services's Eli Lilly position peaked at $228M in Q4 2025.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.